SINGAPORE (Aug 14): Healthcare operator Thomson Medical Group plans to establish in-vitro fertilisation (IVF) centres in China and other Southeast Asian markets, in collaboration with assisted reproduction specialist IVI-RMA.

Thomson Medical is looking to set up about two IVF centres in China, and another in Vietnam within the next 12 to 18 months, executive chairman Roy Quek told The Edge Singapore on Aug 14. These will be in the form of joint ventures with IVI-RMA, and may involve healthcare operators in the respective countries.

See: Thomson Medical enters assisted reproduction JV with IVI-RMA Global

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook